Protein kinase

Enzyme that adds phosphate groups to other proteins

General scheme of kinase function

A protein kinase is a kinase which selectively modifies other proteins by covalently adding phosphates to them (phosphorylation) as opposed to kinases which modify lipids, carbohydrates, or other molecules. Phosphorylation usually results in a functional change of the target protein (substrate) by changing enzyme activity, cellular location, or association with other proteins. The human genome contains about 500 protein kinase genes and they constitute about 2% of all human genes.[1] There are two main types of protein kinase. The great majority are serine/threonine kinases, which phosphorylate the hydroxyl groups of serines and threonines in their targets. Most of the others are tyrosine kinases, although additional types exist.[2] Protein kinases are also found in bacteria and plants. Up to 30% of all human proteins may be modified by kinase activity, and kinases are known to regulate the majority of cellular pathways, especially those involved in signal transduction.

## Chemical activity

[edit]

Above is a ball-and-stick model of the inorganic phosphate molecule (HPO42−). Colour coding: P (orange); O (red); H (white).

The chemical activity of a protein kinase involves removing a phosphate group from ATP and covalently attaching it to one of three amino acids that have a free hydroxyl group. Most kinases act on both serine and threonine, others act on tyrosine, and a number (dual-specificity kinases) act on all three.[3] There are also protein kinases that phosphorylate other amino acids, including histidine kinases that phosphorylate histidine residues.[4]

## Structure

[edit]

Main article: Protein kinase domain

Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins that share a conserved catalytic core.[5][6][7][8] The structures of over 280 human protein kinases have been determined.[9]

There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine amino acid, which has been shown to be involved in ATP binding. In the central part of the catalytic domain, there is a conserved aspartic acid, which is important for the catalytic activity of the enzyme.[10]

## Serine/threonine-specific protein kinases

[edit]

Calcium/calmodulin-dependent protein kinase II (CaMKII) is an example of a serine/threonine-specific protein kinase.

Main article: Serine/threonine-specific protein kinases

Serine/threonine protein kinases (EC 2.7.11.1) phosphorylate the OH group of serine or threonine (which have similar side chains). Activity of these protein kinases can be regulated by specific events (e.g., DNA damage), as well as numerous chemical signals, including cAMP/cGMP, diacylglycerol, and Ca2+/calmodulin. One very important group of protein kinases are the MAP kinases (acronym from: "mitogen-activated protein kinases"). Important subgroups are the kinases of the ERK subfamily, typically activated by mitogenic signals, and the stress-activated protein kinases JNK and p38. While MAP kinases are serine/threonine-specific, they are activated by combined phosphorylation on serine/threonine and tyrosine residues. Activity of MAP kinases is restricted by a number of protein phosphatases, which remove the phosphate groups that are added to specific serine or threonine residues of the kinase and are required to maintain the kinase in an active conformation.[11]

## Tyrosine-specific protein kinases

[edit]

Main article: Tyrosine kinase

Tyrosine-specific protein kinases (EC 2.7.10.1 and EC 2.7.10.2) phosphorylate tyrosine amino acid residues, and like serine/threonine-specific kinases are used in signal transduction. They act primarily as growth factor receptors and in downstream signaling from growth factors.[12] Some examples include:

* Platelet-derived growth factor receptor (PDGFR)
* Epidermal growth factor receptor (EGFR)[13]
* Insulin receptor and insulin-like growth factor 1 receptor (IGF1R)
* Stem cell factor (SCF) receptor (also called c-kit, see the article on gastrointestinal stromal tumor).

### Receptor tyrosine kinases

[edit]

Main article: Receptor tyrosine kinase

These kinases consist of extracellular domains, a transmembrane spanning alpha helix, and an intracellular tyrosine kinase domain protruding into the cytoplasm. They play important roles in regulating cell division, cellular differentiation, and morphogenesis. More than 50 receptor tyrosine kinases are known in mammals.[14]

#### Structure

[edit]

The extracellular domains serve as the ligand-binding part of the molecule, often inducing the domains to form homo- or heterodimers. The transmembrane element is a single α helix. The intracellular or cytoplasmic Protein kinase domain is responsible for the (highly conserved) kinase activity, as well as several regulatory functions.[citation needed]

#### Regulation

[edit]

Ligand binding causes two reactions:

1. Dimerization of two monomeric receptor kinases or stabilization of a loose dimer. Many ligands of receptor tyrosine kinases are multivalent. Some tyrosine receptor kinases (e.g., the platelet-derived growth factor receptor) can form heterodimers with other similar but not identical kinases of the same subfamily, allowing a highly varied response to the extracellular signal.
2. Trans-autophosphorylation (phosphorylation by the other kinase in the dimer) of the kinase.

Autophosphorylation stabilizes the active conformation of the kinase domain. When several amino acids suitable for phosphorylation are present in the kinase domain (e.g., the insulin-like growth factor receptor), the activity of the kinase can increase with the number of phosphorylated amino acids; in this case, the first phosphorylation switches the kinase from "off" to "standby".

#### Signal transduction

[edit]

The active tyrosine kinase phosphorylates specific target proteins, which are often enzymes themselves. An important target is the ras protein signal-transduction chain.[citation needed]

### Receptor-associated tyrosine kinases

[edit]

Main article: Non-receptor tyrosine kinase

Tyrosine kinases recruited to a receptor following hormone binding are receptor-associated tyrosine kinases and are involved in a number of signaling cascades, in particular those involved in cytokine signaling (but also others, including growth hormone). One such receptor-associated tyrosine kinase is Janus kinase (JAK), many of whose effects are mediated by STAT proteins. (See JAK-STAT pathway.)

## Dual-specificity protein kinases

[edit]

Main article: Dual-specificity kinase

Some kinases have dual-specificity kinase activities. For example, MEK (MAPKK), which is involved in the MAP kinase cascade, is a both a serine/threonine and tyrosine kinase.

## Histidine-specific protein kinases

[edit]

Histidine kinases are structurally distinct from most other protein kinases and are found mostly in prokaryotes as part of two-component signal transduction mechanisms. A phosphate group from ATP is first added to a histidine residue within the kinase, and later transferred to an aspartate residue on a 'receiver domain' on a different protein, or sometimes on the kinase itself. The aspartyl phosphate residue is then active in signaling.

Histidine kinases are found widely in prokaryotes, as well as in plants, fungi and eukaryotes. The pyruvate dehydrogenase family of kinases in animals is structurally related to histidine kinases, but instead phosphorylate serine residues, and probably do not use a phospho-histidine intermediate.

## Aspartic acid/glutamic acid-specific protein kinases

[edit]

This section needs expansion. You can help by adding to it. (June 2008)

|

## Inhibitors

[edit]

Main article: Protein kinase inhibitor

Deregulated kinase activity is a frequent cause of disease, in particular cancer, wherein kinases regulate many aspects that control cell growth, movement and death. Drugs that inhibit specific kinases are being developed to treat several diseases, and some are currently in clinical use, including Gleevec (imatinib) and Iressa (gefitinib).

* Anthra(1,9-cd)pyrazol-6(2H)-one
* Staurosporine

## Kinase assays and profiling

[edit]

Drug developments for kinase inhibitors are started from kinase assays Archived 2014-11-26 at the Wayback Machine, the lead compounds are usually profiled for specificity before moving into further tests. Many profiling services are available from fluorescent-based assays to radioisotope based detections, and competition binding assays.

## References

[edit]

1. ^ Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002). "The protein kinase complement of the human genome". Science. 298 (5600): 1912–1934\. Bibcode:2002Sci...298.1912M. doi:10.1126/science.1075762. PMID 12471243. S2CID 26554314.
2. ^ Alberts, Bruce (18 November 2014). Molecular biology of the cell (Sixth ed.). New York. pp. 819–820\. ISBN 978-0-8153-4432-2. OCLC 887605755.`{{cite book}}`: CS1 maint: location missing publisher (link)
3. ^ Dhanasekaran N, Premkumar Reddy E (September 1998). "Signaling by dual specificity kinases". Oncogene. 17 (11 Reviews): 1447–55\. doi:10.1038/sj.onc.1202251. PMID 9779990. S2CID 9299657.
4. ^ Besant PG, Tan E, Attwood PV (March 2003). "Mammalian protein histidine kinases". Int. J. Biochem. Cell Biol. 35 (3): 297–309\. doi:10.1016/S1357-2725(02)00257-1. PMID 12531242.
5. ^ Hanks SK (2003). "Genomic analysis of the eukaryotic protein kinase superfamily: a perspective". Genome Biol. 4 (5): 111. doi:10.1186/gb-2003-4-5-111. PMC 156577. PMID 12734000.
6. ^ Hanks SK, Hunter T (May 1995). "Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification". FASEB J. 9 (8): 576–96\. doi:10.1096/fasebj.9.8.7768349. PMID 7768349. S2CID 21377422.
7. ^ Hunter T (1991). "Protein kinase classification". Protein Phosphorylation Part A: Protein Kinases: Assays, Purification, Antibodies, Functional Analysis, Cloning, and Expression. Methods in Enzymology. Vol. 200\. pp. 3–37\. doi:10.1016/0076-6879(91)00125-G. ISBN 9780121821012. PMID 1835513.
8. ^ Hanks SK, Quinn AM (1991). "Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members". Protein Phosphorylation Part A: Protein Kinases: Assays, Purification, Antibodies, Functional Analysis, Cloning, and Expression. Methods in Enzymology. Vol. 200\. pp. 38–62\. doi:10.1016/0076-6879(91)00126-H. ISBN 9780121821012. PMID 1956325.
9. ^ Modi, V; Dunbrack, RL (2019-12-24). "A Structurally-Validated Multiple Sequence Alignment of 497 Human Protein Kinase Domains". Scientific Reports. 9 (1): 19790. Bibcode:2019NatSR...919790M. doi:10.1038/s41598-019-56499-4. PMC 6930252. PMID 31875044.
10. ^ Knighton DR, Zheng JH, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS, Sowadski JM (July 1991). "Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase". Science. 253 (5018): 407–14\. Bibcode:1991Sci...253..407K. doi:10.1126/science.1862342. PMID 1862342.
11. ^ Hanks, Steven K.; Hunter, Tony (1995). "The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification". The FASEB Journal. 9 (8): 576–596\. doi:10.1096/fasebj.9.8.7768349. ISSN 1530-6860.
12. ^ Higashiyama S, Iwabuki H, Morimoto C, Hieda M, Inoue H, Matsushita N. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 2008 Feb;99(2):214-20. Review. PMID: 18271917
13. ^ Carpenter G. The EGF receptor: a nexus for trafficking and signaling. Bioessays. 2000 Aug;22(8):697-707. Review. PMID: 10918300
14. ^ Robinson, Dan R.; Wu, Yi-Mi; Lin, Su-Fang (November 2000). "The protein tyrosine kinase family of the human genome". Oncogene. 19 (49): 5548–5557\. doi:10.1038/sj.onc.1203957. ISSN 1476-5594. PMID 11114734.

## External links

[edit]

* Biology portal

* Human and mouse protein kinases in UniProt: classification and index
* Kinase.Com: Genomics, evolution and large-scale analysis of protein kinases (non-commercial).
* KinMutBase: A registry of disease-causing mutations in protein kinase domains Archived 2022-06-15 at the Wayback Machine
* KLIFS (Kinase-Ligand Interaction Fingerprints and Structures) Database -- analysis of kinase structures and kinase-inhibitor interactions
* KinCore: the Kinase Conformation Resource: A web resource for protein kinase sequence, structure and phylogeny
* Kinomer: A multilevel HMM library for the classification and functional annotation of eukaryotic protein kinases.

* v
* t
* e

Intracellular signaling peptides and proteins

MAP|

* see MAP kinase pathway

Calcium|

* Intracellular calcium-sensing proteins
* Calcineurin
* Ca2+/calmodulin-dependent protein kinase

G protein|

| Heterotrimeric|

| cAMP:|

* Heterotrimeric G protein
* Gs/Gi
* Adenylate cyclase
* cAMP
* 3',5'-cyclic-AMP phosphodiesterase
* Protein kinase A

|

cGMP:|

* Transducin
* Gustducin
* Guanylate cyclase
* cGMP
* 3',5'-cyclic-GMP phosphodiesterase
* Protein kinase G

* G alpha subunit Gα
* GNAO1
* GNAI1
* GNAI2
* GNAI3
* GNAT1
* GNAT2
* GNAT3
* GNAZ
* GNAS
* GNAL
* GNAQ
* GNA11
* GNA12
* GNA13
* GNA14
* GNA15/GNA16

* G beta-gamma complex Gβ
* GNB1
* GNB2
* GNB3
* GNB4
* GNB5
* Gγ
* GNGT1
* GNGT2
* GNG2
* GNG3
* GNG4
* GNG5
* GNG7
* GNG8
* GNG10
* GNG11
* GNG12
* GNG13
* BSCL2

* G protein-coupled receptor kinase
* AMP-activated protein kinase

Monomeric|

* ARFs
* Rabs
* Ras
* HRAS
* KRAS
* NRAS
* Rhos
* Arfs
* Ran
* Rhebs
* Raps
* RGKs

Cyclin|

* Cyclin-dependent kinase inhibitor protein
* Cyclin-dependent kinase
* Cyclin

Lipid|

* Phosphoinositide phospholipase C
* Phospholipase C

Other protein kinase|

| Serine/threonine:|

* Casein kinase
* 1
* 2
* eIF-2 kinase
* EIF2AK3
* Glycogen synthase kinase
* GSK1
* GSK2
* GSK-3
* GSK3A
* GSK3B
* IκB kinase
* CHUK
* IKK2
* IKBKG
* Interleukin-1 receptor associated kinase
* IRAK1
* IRAK2
* IRAK3
* IRAK4
* Lim kinase
* LIMK1
* LIMK2
* p21-activated kinases
* PAK1
* PAK2
* PAK3
* PAK4
* Rho-associated protein kinase
* ROCK1
* ROCK2
* Ribosomal s6 kinase
* RPS6KA1

|

Tyrosine:|

* ZAP70
* Focal adhesion protein-tyrosine kinase
* PTK2
* PTK2B
* BTK

Serine/threonine/tyrosine|

* Dual-specificity kinase
* DYRK1A
* DYRK1B
* DYRK2
* DYRK3
* DYRK4

Arginine|

* Arginine kinase
* McsB

Other protein phosphatase|

| Serine/threonine:|

* Protein phosphatase 2

|

Tyrosine:|

* protein tyrosine phosphatase: Receptor-like protein tyrosine phosphatase
* Sh2 domain-containing protein tyrosine phosphatase

both:|

* Dual-specificity phosphatase

Apoptosis|

* see apoptosis signaling pathway

GTP-binding protein regulators|

* see GTP-binding protein regulators

Other|

* Activating transcription factor 6
* Signal transducing adaptor protein
* I-kappa B protein
* Mucin-4
* Olfactory marker protein
* Phosphatidylethanolamine binding protein
* EDARADD
* PRKCSH

see also deficiencies of intracellular signaling peptides and proteins

* v
* t
* e

Transferases: phosphorus-containing groups (EC 2.7)

2.7.1-2.7.4:
phosphotransferase/kinase
(PO4)|

| 2.7.1: OH acceptor|

* Hexo-
* Gluco-
* Fructo-
* Hepatic
* Galacto-
* Phosphofructo-
* 1
* Liver
* Muscle
* Platelet
* 2
* Riboflavin
* Shikimate
* Thymidine
* ADP-thymidine
* NAD+
* Glycerol
* Pantothenate
* Mevalonate
* Pyruvate
* Deoxycytidine
* PFP
* Diacylglycerol
* Phosphoinositide 3
* Class I PI 3
* Class II PI 3
* Sphingosine
* Glucose-1,6-bisphosphate synthase

|

2.7.2: COOH acceptor|

* Phosphoglycerate
* Aspartate kinase

2.7.3: N acceptor|

* Creatine

2.7.4: PO4 acceptor|

* Phosphomevalonate
* Adenylate
* Nucleoside-diphosphate
* Uridylate
* Guanylate
* Thiamine-diphosphate

2.7.6: diphosphotransferase
(P2O7)|

* Ribose-phosphate diphosphokinase
* Thiamine diphosphokinase

2.7.7: nucleotidyltransferase
(PO4-nucleoside)|

| Polymerase|

| DNA polymerase|

DNA-directed DNA polymerase
I/A

Taq
II/B

Pfu
III/C
IV/X

TDT
V/Y

RNA-directed DNA polymerase
Reverse transcriptase

Telomerase

|

RNA polymerase|

Template-directed
RNA polymerase I

III

ssRNAP

POLRMT
Primase

PrimPol
RNA-dependent RNA polymerase
Polyadenylation
PAP
PNPase

Phosphorolytic
3' to 5' exoribonuclease|

* RNase PH
* PNPase

Nucleotidyltransferase|

* UTP—glucose-1-phosphate uridylyltransferase
* Galactose-1-phosphate uridylyltransferase

Guanylyltransferase|

* mRNA capping enzyme

Other|

* Recombinase (Integrase)
* Transposase

2.7.8: miscellaneous|

| Phosphatidyltransferases|

* CDP-diacylglycerol—glycerol-3-phosphate 3-phosphatidyltransferase
* CDP-diacylglycerol—serine O-phosphatidyltransferase
* CDP-diacylglycerol—inositol 3-phosphatidyltransferase
* CDP-diacylglycerol—choline O-phosphatidyltransferase

|

Glycosyl-1-phosphotransferase|

* N-acetylglucosamine-1-phosphate transferase

2.7.10-2.7.13: protein kinase
(PO4; protein acceptor)|

| 2.7.10: protein-tyrosine|

* see tyrosine kinases

|

2.7.11: protein-serine/threonine|

* see serine/threonine-specific protein kinases

2.7.12: protein-dual-specificity|

* see serine/threonine-specific protein kinases

2.7.13: protein-histidine|

* Protein-histidine pros-kinase
* Protein-histidine tele-kinase
* Histidine kinase

* v
* t
* e

Enzymes

Activity|

* Active site
* Binding site
* Catalytic triad
* Oxyanion hole
* Enzyme promiscuity
* Diffusion-limited enzyme
* Cofactor
* Enzyme catalysis

Regulation|

* Allosteric regulation
* Cooperativity
* Enzyme inhibitor
* Enzyme activator

Classification|

* EC number
* Enzyme superfamily
* Enzyme family
* List of enzymes

Kinetics|

* Enzyme kinetics
* Eadie–Hofstee diagram
* Hanes–Woolf plot
* Lineweaver–Burk plot
* Michaelis–Menten kinetics

Types|

* EC1 Oxidoreductases (list)
* EC2 Transferases (list)
* EC3 Hydrolases (list)
* EC4 Lyases (list)
* EC5 Isomerases (list)
* EC6 Ligases (list)
* EC7 Translocases (list)

Authority control databases: National |

* Japan
* Czech Republic

|

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template